HTA225 A Review of External Evidence Used to Support Survival Extrapolation in Assessments of Cancer Drugs by the National Institute for Health and Care Excellence (NICE)
Abstract
Authors
A Bullement S Critchlow MD Stevenson G Baio N Latimer